Research Capabilities
Printer-friendly version
Send to friend
Distinctive Qualities:
Designated as one of five Cardiovascular Stem Cell Research Centers by NIH.
Survival rate from the Level One Heart Attack Program is one of the highest nationally.
Developed national guidelines for cardiovascular screening of athletes.
Led creation of the national Peripheral Vascular guidelines issued by NIH.
High service, high staff organization with a large volume of cardiovascular services.
Over 140 IRB approved studies.
24 Databases and registries that are among the largest in the United States for STEMI, Refractory Ischemia, cardiovascular imaging, Hypertrophic Cardiomyopathy and Complex Valve Disorder.
In 2008, reported results in over 80 peer-reviewed publications and in over 130
presentations at AHA, ACC, HRS, TCT, VIVA and other major meetings.
Facilities and Technology:
128 bed state-of-the-art heart hospital built in 2005.
Almost 8,000 inpatient discharges, over 2,500 PCIs and over 1,900
electrophysiology cases in 2008.
Minneapolis Heart Institute served 70,000 patients at its clinics and hospitals in 2008.
Approximately 45 AMI patients per month.
Research outreach sites in Brainerd and Waconia.
Advanced cardiovascular imaging technology including a Magnetom Avanto 1.5T MRI and a dual source 64-slice Somatom CT.
5 cath lab suites.
4 operating suites.
4 Electrophysiology suites with robot-guided capabilities.
1 Endovascular suite.
NOGA XP.
Staff Expertise:
Broad research experience among 59 Minneapolis Heart Institute physician investigators.
Advanced clinical cardiovascular research experience among 44 research staff,
including 23 coordinators (17 who are CCRC certified) and 19 RNs.
Director of Medical Research with over 20 years of extensive clinical research experience.